Nimble Therapeutics

About:

Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.

Website: https://www.nimbletherapeutics.com/

Top Investors: Telegraph Hill Partners

Description:

Nimble Therapeutics is a developer of a drug discovery platform intended to bring the power of massively parallel chemical synthesis to drug discovery. The company uses its unique maskless chemical synthesis platform to synthesize and systematically discover novel medicines in a variety of therapeutic areas, providing customers aid in the empirical optimization of molecules with more favorable drug-like properties.

Total Funding Amount:

$10M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)nimbletherapeutics.com

Founders:

Jigar Patel

Number of Employees:

11-50

Last Funding Date:

2019-04-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai